The interleukin-3 dependent murine Ba/F3 cell line has been widely used as an experimental model of cell transformation by BCR ± ABL oncogenes as assessed by induction of growth-factor-independence and inhibition of apoptosis in vitro. The signaling pathways used by BCR ± ABL oncogenes to exert these eects are unknown. To gain insights into this phenomenon, we have introduced the p190-and p210-encoding BCR ± ABL oncogenes as well as the constitutively activated oncogenic murine erythropoietin receptor (cEpoR) into Ba/F3 and compared the behavior of individual clones in response to apoptotic stimuli. Both p210 and p190 BCR ± ABL vectors induced IL-3-independent growth and the same result was obtained with the cEpo-R vector. Individual clones of Ba/F3 cells expressing BCR ± ABL exhibited signi®cant resistance to apoptosis induced by either etoposide, serum deprivation or growth-factor withdrawal. In contrast, Ba/F3 cells expressing the constitutively active cEpoR behaved like parental Ba/F3 cells undergoing apoptosis when similarly treated with etoposide or upon serum deprivation. Bc12 and Bax levels were similar in all BCR ± ABL and cEpoR-transfected clones. However, in band-shift assays, nuclear extracts from growth-factor-independent Ba/F3 clones expressing cEpoR had no detectable STAT activity as opposed to the constitutive STAT activation detected in all Ba/F3 clones expressing p210 or p190 BCR ± ABL. Our results indicate that although both constitutively activated cEpoR and BCR ± ABL oncogenes induce growth-factor independence in Ba/F3 cells, only BCR ± ABL is able to protect cells from etoposide and serum-deprivation-induced apoptosis and induce a strong constitutive activation of STAT factors, suggesting a role for these molecules in the anti-apoptotic activity of BCR ± ABL.
Introduction
The chimeric fusion gene BCR ± ABL is the molecular hallmark of chronic myelogenous leukemia (CML) (Kurzrock et al., 1988) . The molecular mechanisms of BCR ± ABL-induced-cell transformation have been extensively studied during recent years in experimental systems such as the IL-3-dependent murine cell line Ba/ F3, to demonstrate the oncogenic potential of BCR ± ABL oncogenes (Daley and Baltimore, 1988; McWhirter and Wang, 1993; Kabarowski et al., 1994) . In several hematopoietic cell lines tested including Ba/F3, BCR ± ABL has been shown to induce growth-factorindependence and to confer a strong antiapoptotic eect Kabarowski et al., 1994) . However, recent data indicate that the obtention of a fully transformed phenotype by BCR ± ABL is a complex event requiring multiple activation signals (Puil et al., 1994; Salgia et al., 1996; Carpino et al., 1997; Jain et al., 1997) and an appropriate cellular context (Ilaria and Van Etten, 1995; Goga et al., 1995) . Some domains of BCR ± ABL molecule might also have dierent roles in terms of growth-factor independence inducing ability, proliferation or inhibition of apoptosis (Pendergast et al., 1993a; Cortex et al., 1995) the latter being probably a major mechanism by which BCR ± ABL could exert its transforming eect, perhaps by predisposing cells to a cytogenetic instability (Bedi et al., 1994) .
The precise mechanisms of the antiapoptotic eects of BCR ± ABL oncogenes remain unknown but it has been assumed that they might act, at least in the context of a growth-factor-dependent cell line, by replacing the action of a growth factor to which the target cell is usually responsive (Sirard et al., 1994) . Although current experimental data indicate that BCR ± ABL could activate several growth-factorinduced signaling pathways (Puil et al., 1994; Pendergast et al., 1993b; Carlesso et al., 1996) there is no evidence demonstrating the presence of a common pathway for growth-factor-independence and inhibition of apoptosis. As a matter of fact, even growth factors such as IL-3 and GM-CSF which are the prototypes of antiapoptotic molecules, could use dierential signaling for their proliferative and their anti-apoptotic eects (Kinoshita et al., 1995) .
In this work, we wished to study the relationships between growth-factor-independence and the antiapoptotic activity of BCR ± ABL. We have used for this purpose Ba/F3 cell line which we rendered growthfactor-independent by enforced expression of either BCR ± ABL oncogenes (p210 and p190) or the constitutively active form of the EpoR harboring an Arginine-Cysteine (R129C) mutation (Watowich et al., 1992) . The latter has been shown to induce a strong proliferative and transforming eect of hematopoietic progenitor cells in mice (Longmore et al., 1994) . The antiapoptotic potential of both BCR ± ABL and cEpoR was therefore assessed in the same cellular context. Our results indicate that although both BCR ± ABL and cEpoR render Ba/F3 cells growth-factor-independent, only BCR ± ABL is able to inhibit serum-deprivation and etoposide-induced apoptosis. This dierential eect was correlated with a dierential activation of STAT molecules.
Results

Expression of BCR ± ABL and cEpoR in Ba/F3 cells
All Ba/F3 cells transfected with BCR ± ABL plasmids and ampli®ed in the presence of WEHI-CM and G418 were found to be growth-factor-independent upon removal of IL-3. Similarly, growth-factor-independence were readily obtained in Ba/F3 cells transfected with cEpoR plasmids. Figure 1 shows a Western blot analysis of individual Ba/F3 clones expressing BCR ± ABL p190 (Clones #6, 4 and 3) and BCR ± ABL p210 (Clones #6, 5 and 3) constructs. Four clones designated as p210-C5, p210-C6, p190-C3 and p190-C6 were selected for functional analyses.
To demonstrate the presence of cEpoR expression at the surface of Ba/F3 cells transfected with the cEpoR construct, we used a radioactive Epo-binding assay on four individual clones as well as on the polyclonal Ba/ F3-cEpoR stock. As can be seen in Figure 2 , all clones as well as the polyclonal cEpoR stock bound very eciently iodinated Epo, with the highest binding being observed on clone cEpoR-C3. As expected, no Epo-binding was detectable on the parental BaF3 cell line. The level of cEpoR binding observed on the polyclonal stock was similar to that observed on clones cEpoR-C1, cEpoR-C5 and cEpoR-C8. These results clearly demonstrated expression of cEpoR at the surface of all Ba/F3 transfectants.
Comparative analysis of growth characteristics of Ba/F3 BCR ± ABL and Ba/F3-cEpoR clones Growth characteristics of BCR ± ABL clones (p210-C5, p210-C6, p190-C3 and p210-C6) were compared to that observed in a Ba/F3 clone transfected with a NeoR gene as well as to that seen in two Ba/F3-cEpoR clones (cEpoR-C3 and cEpoR-C5). Figure 3 shows the results of a 3 H-thymidine proliferation assay demonstrating growth factor independence of the clones p210-C5 and p210-C6 and that of the clones p190-C3 and p190-C6. Upon stimulation by IL-3, these clones did not exhibit an increased proliferative response. On the other hand, clones cEpoR-C3 and cEpoR-C5 expressing cEpoR at their surface, showed a reduced growth in the absence of IL-3 despite their growth-factor-independence. Their growth could further be enhanced by exogenous IL-3 (10% WEHI-conditioned medium). Similar results were obtained with MTT and daily viability count analyses (data not shown). Altogether, these data demonstrated that the expression of cEpoR at the surface of Ba/F3 cells induced growth-factor-independence similar to the phenomenon observed with the expression of BCR ± ABL oncogenes whereas cells transfected with NeoR gene remained strictly growth-factor-dependent ( Figure 3 ). BCR ± ABL and cEpoR clones as well as control Ba/F3 cells were then tested for their ability to resist to apoptotic signals. I-Epo in the absence (total binding) or in the presence of 500 nM unlabeled Epo (NSB: non-speci®c binding). After 1 h at 378C, the cells were washed and cell-bound radioactivity was measured. Each point is the mean of three determinations Inhibition of apoptosis by BCR ± ABL Figure 4 shows the results of a representative quantitative propidium iodide assay in all clones expressing BCR ± ABL and cEpoR as well as in control NeoR and parental cells to determine the percentage of apoptotic nuclei. The results obtained represent the mean of three separate experiments. At the beginning of the experiments, spontaneous apoptosis rate was low in all clones (55% apoptotic nuclei). Apoptosis was induced by growth-factor withdrawal, serum deprivation or by the use of etoposide.
As shown in Figure 4b , IL-3 withdrawal for 48 h induced apoptosis in both parental and Ba/F3 NeoRcells (53% and 63% apoptotic nuclei respectively). On the other hand, upon removal of IL-3, all BCR ± ABLexpressing clones (p210-C5, p210-C6, p190-C3 and p190-C6) remained non-apoptotic for 48 h (mean percentage of apoptosis: 8% for Ba/F3-p210 and 7% for Ba/F3-p190 clones). Similarly, cEpoR transfectants cEpoR-C3 and cEpoR-C5 grown without IL-3 in 10% FCS were not apoptotic for over 48 h (11% and 7% of apoptotic nuclei) ( Figure 4b ). This latter ®nding suggested that the constitutive activation of cEpoR was sucient to transmit a mitogenic signal, circumventing the need for the exogenously provided IL-3.
We have therefore compared BCR ± ABL and cEpoR transfectants for their behavior with regard to the use of other apoptotic stimuli such as serum deprivation and use of etoposide. As can be seen in Figure 4c ; serum deprivation for 48 h induced a signi®cant apoptosis in both parental and control Ba/ F3-NeoR cells (45% and 56% of apoptotic nuclei respectively). Conversely, all BCR ± ABL clones remained totally resistant to apoptosis induced by serum deprivation in the same period of time (4 ± 8% of apoptotic nuclei in all clones). Interestingly, growthfactor-independent Ba/F3-cEpoR clones were not resistant to serum-deprivation-induced apoptosis, with a mean % of 36 ± 42% of apoptotic nuclei observed after 48 h of serum deprivation (Figure 4c ). This discordant behavior between BCR ± ABL and cEpoR transfectants was also found when cells were treated with an optimal dose of etoposide known to induce apoptosis in our Ba/F3 cell line. Upon etoposide treatment for 20 h (20 mg/ml) all BCR ± ABL clones remained non-apoptotic (9 ± 10% apoptotic nuclei for p210 clones and 8% for p190 clones) whereas parental cells and Ba/F3-NeoR cells underwent a signi®cant degree of apoptosis (41% apoptotic nuclei for parental cells and 51% for NeoR cells). Similarly, both growthfactor-independent cEpoR clones expressing cEpoR at their surface were not protected from the etoposideinduced apoptosis (34% and 36% of apoptotic nuclei in both clones) ( Figure 4d ) suggesting that growth factor-independence provided by the constitutive activation of cEpoR was not sucient to transmit an antiapoptotic signal, this eect contrasting with the antiapoptotic eect constantly observed in Ba/F3-BCR ± ABL clones. Thus, despite the established oncogenicity of both BCR ± ABL and cEpoR, there was a clear dissociation between the antiapoptotic eect of these two genes in the same cellular context.
Bc12 and Bax expression in BCR ± ABL and cEpoR clones
In order to gain insight into the mechanisms of the dierential antiapoptotic eect provided by BCR ± ABL and cEpoR, we next studied the expression of Bc12 and Bax protein in our clones. Figure 5 shows the result of a Western blot analysis using a Bc12 antibody. As shown in this Figure, we did not ®nd any signi®cant dierence of Bc12 protein levels in cells expressing BCR ± ABL or cEpoR. However, control Ba/F3 cells (parental or transfected with a NeoR gene) expressed lower levels of Bc12. Similarly, we did not observe any signi®cant dierences in the levels of the Western blot analysis of BCR ± ABL p210, p190 and cEpoR clones to determine Bc12 expression (p25 Bc12). A consistent increase of the Bc12 levels was found in BCR ± ABL and in cEpoR clones as opposed to control cells proapoptotic protein Bax between our BCR ± ABL and cEpoR transfectants ( Figure 6 ).
Comparative analysis of STAT activation in BCR ± ABL and cEpoR clones
Cytokines such as IL3 and Epo induce activation of STAT factors in hematopoietic cells. This signaling pathway has been shown to be constitutively activated in cells expressing some oncogenes such as v-src (Yu et al., 1995; Cao et al., 1996) and v-ABL (Danial et al., 1995) or in lymphocytes infected by HTLV-1 retrovirus (Migone et al., 1995) , with a strong correlation between cell transformation or transition from a cytokinedependent to a cytokine-independent growth with STAT activation. We therefore examined the activation of STAT factors in Ba/F3 cells expressing BCR ± ABL or cEpoR oncogenes. Nuclear extracts from permanently growing Ba/F3-p210, Ba/F3-p190 and BaF3-cEpoR clones were prepared. The presence of active STAT factors was tested by their ability to bind to three dierent STAT binding sequences, namely the sis-induced element (SIE) from the c-fos promoter, the IFN-g activated sequence (GAS) from the interferon regulatory factor-1 (IRF-1) promoter and the GAS from the b-casein promoter. Each of these sequences exhibit a dierent level of anity for the STATs identi®ed at the present time and often preferentially detects one or two active STATs. As shown in Figure  7 , neither the polyclonal stock (lanes 1, 5 and 9) nor the Ba/F3 clones expressing high amount of cEpoR at their surface (lanes 14 and 15) were able to induce STAT factor activation with DNA binding activity for any of the GAS used. As expected, control Ba/F3 cells expressing the neomycin resistance gene were able to respond to IL-3 and IFN-g stimulation by activation of STAT5 (lanes 3, 7 and 11) and STAT 1 (lanes 4, 8 and 12), respectively, as previously described . In the same conditions, STAT factors were constitutively activated in cells expressing p190 (lanes 2, 6 and 10) and p210 (lane 16) BCR ± ABL oncogenes. Supershift experiments further indicated that BCR ± ABL oncogenes preferentially activated STAT5A, STAT5B and STAT6, with a much weaker activation of STAT1 (data not shown).
Discussion
Inhibition of apoptosis seems to be one of the major eects of BCR ± ABL oncogenes (Bedi et al., 1994; Kobarowski et al., 1994) . Although the exact mechanisms of this phenomenon are not clearly understood, it is thought to be a direct consequence of the presence of the BCR ± ABL fusion protein inside the cell, rather than being a secondary event. Experimental data in favor of this hypothesis include the reversal of the antiapoptotic eect upon treatment of the transformed cells with BCR ± ABL anti-sense oligonucleotides (McGahon et al., 1994) as well as with speci®c inhibitors of the ab1 tyrosine kinase activity (Druker et al., 1996) . The relationships between growth-factor-independence and the antiapoptotic eect induced by BCR ± ABL in hematopoietic cell lines are unclear. Experiments using a BCR ± ABL deletion mutant (delta 176 ± 427) in murine 32D cells have shown that the antiapoptotic eect of BCR ± ABL could be dissociated from its proliferative eect with activation of Ras and inhibition apoptosis but absence of growthfactor-independence (Cortex et al., 1995) . On the other hand, growth-factor-independence is probably not an absolute requirement for the antiapoptotic action of BCR ± ABL, as v-ABL has been shown to protect the autonomously growing cell line HL-60 from FASinduced apoptosis (McGahon et al., 1995) . There is however, growing evidence indicating that BCR ± ABL could use the same signaling pathways as some growthfactor-receptors to induce cell transformation. First, BCR ± ABL has been shown to lead to constitutive activation of ras pathway through binding of GRB-2 to Y177 of the BCR ± ABL molecule (Pendergast et al., 1993b) . A number of cytokines such as IL-3, GM-CSF and Steel factor activate also the ras pathway by tyrosine phosphorylation of SHC and its binding to GRB2, leading to an increase of ras-GTP, which in turn activates Raf and the MAP-kinase (Sato et al., 1993) . However, although ras activation is sucient to induce a proliferative response in ®broblastes such as 3T3 cells (Marshall, 1995) , IL-3 or Steel-factor-induced ras activation in hematopoietic cells can preferentially induce a survival or proliferative response depending on the cytokine used (O'Farrell et al., 1996) . Similarly, inhibition of ras pathway by a dominant-negative ras in 32D cells blocks the IL-3-induced proliferation without interfering with the dierentiation induced by G-CSF (Okuda et al., 1994) . cEpo-R-pcl p190-C6
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Figure 7 Analysis of the activation of STAT factors. Nuclear extracts from permanently growing Ba/F3 cells expressing BCR ± ABL (p190-C6 or p210-C5) or cEpoR (cEpoR-polyclonal stock, cEpoR-C3, cEpoR-C5) oncogenes, or from Ba/F3-NeoR cells stimulated in the presence of IL-3 or IFN-g were prepared and analysed by EMSA using as a probe, either the SIE (lanes 1 ± 4) or the IRF1-GAS (lanes 5 ± 8 and 12 ± 16) or the b-casein-GAS (lanes 5 ± 8)-containing oligonucleotide. The dierence in the mobility of the major complexes activated in the presence of IL-3 and IFN-g re¯ects the dominant activation of STAT5 and STAT1 in the presence of these two cytokines, respectively. The left and right panels represent two dierent EMSAs
The second evidence of the involvement of the BCR ± ABL in the growth-factor-induced signaling pathways has been obtained by experiments demonstrating constitutive activation of STAT molecules in hematopoietic cell lines after v-ABL or BCR ± ABL gene transfer (Danial et al., 1995; Carlesso et al., 1996) or the necessity of an intact phosphatidylinositol 3' kinase pathway for obtention of a transforming eect (Skorski et al., 1995) . There is no evidence yet linking disruption of these pathways to the reversal of the antiapoptotic eect induced by BCR ± ABL.
In order to study the relationships between growthfactor-independence and apoptosis, we studied in the same cellular context the eects of two genes rendering Ba/F3 cells factor-independent, i.e., BCR ± ABL oncogenes and constitutively activated cEpoR (Watowich et al., 1992) . The cell lines transfected with p210-BCR ± ABL, p190-BCR ± ABL and cEpoR were growth-factor-independent and their response to growth-factor-deprivation was essentially identical with evidence of protection from apoptosis whereas Ba/F3 cells transfected with a NeoR construct showed signi®cant degree of apoptosis in response to growthfactor-deprivation. However, there was a signi®cant discrepancy between the Ba/F3-cEpoR cells and Ba/ F3 p210 or p190 cells in response to serum deprivation which induced apoptosis in Ba/F3-cEpoR cells whereas Ba/F3-p210 and p190 were resistant (Figure 4 ). Persistent activation of ras pathway in cells expressing BCR ± ABL (Puil et al., 1994) could probably not explain this dierence as there is evidence indicating that hyperexpression of RAS and Rho could predispose cells to serum-deprivationinduced-apoptosis (Esteve et al., 1995; Ferrari and Greene, 1994) . To determine if Ba/F3-cEpoR cells, as opposed to Ba/F3-p210 and Ba/F3-p190, had truly no resistance to apoptosis despite their growth-factorindependence, we have used etoposide as an apoptotic agent. A polyclonal stock of Ba/F3-cEpoR cells as well as all four growth-factor-independent Ba/F3-cEpoR clones expressing signi®cant amounts of cEpoR at their surface were not able to resist to etoposide-induced apoptosis (Figure 4) . Overall, these results suggest strongly that in Ba/F3 cell line antiapoptotic eects and growth-factor-independence can be induced by dierent signaling events. In order to determine if this discordance could be due to the dierential expression of molecules of the Bc12/Bax family, we have performed Western analyses using total cell lysates from our dierent clones. The results of these experiments indicate that there is no signi®cant dierence of Bc12 expression between the apoptosis-resistant BCR ± ABL and the apoptosissensitive cEpoR-transfectants, although our parental Ba/F3 cells seemed to express lower levels of Bc12 ( Figure 5) . Similarly, there was no signi®cant dierence between the BCR ± ABL and cEpoR clones in terms of Bax expression (Figure 6 ). Currently, the only experimental evidence suggesting a direct relationship between BCR ± ABL induced cell-transformation and Bc12-activation is the inhibition of the growth-factor-independent and tumorigenic phenotype of Ba/F3-BCR ± ABL transfectants by the use of an enforced expression of an anti-Bc12 expression vector (Sanchez-Garcia and Grutz 1995). Although our experiments con®rm the increased expression of Bc12 in cells transformed by BCR ± ABL oncogenes, we show here that Ba/F3-cEpoR clones seem to express also a signi®cant amount of Bc12 protein ( Figure 5 ). This ®nding is interesting as Bc12 has been shown to be increasingly implicated in growthfactor-receptor-signaling pathways such as the IL2-receptor signaling (Miyazaki et al., 1995) . More recently, experiments with fusion proteins CD16/ JAK2 in Ba/F3 cells demonstrated that the activation JAK2 kinase by crosslinking of CD16, induces Bc12 expression with inhibition of apoptosis (Sakai and Kraft, 1997) .
In our study, we have also asked whether the dierential behavior of BaF3-cEpoR and BCR ± ABL transfectants could be due to the dierent STAT activation induced by these two types of oncogenes. Our results con®rm previous ®ndings (Carlesso et al., 1996; Ilaria et al., 1996) demonstrating a constitutive activation of STAT factors (STAT 1, 5 and 6) by BCR ± ABL. In contrast, growth-factor-independent Ba/F3 cEpoR polyclonal cells and two independent clones expressing the highest levels of cEpoR at their surface were not able to induce a DNA binding activity on either SIE, IRF-1 or beta-casein STATresponsive sequences (Figure 7) . Although the absence of STAT 1 activity in the nuclear extracts of cEpoRtransfected cells is not surprising, the absence of detectable STAT5 binding activity is an intriguing ®nding as STAT5 is clearly involved in Epo-induced signaling Gobert et al., 1996; Sawyer and Penta, 1996) . One possibility is the presence, in our cEpoR-transfectants, of a low level of STAT5 activation which is not detectable by the currently used oligonucleotide binding assays. This low level of activation would then be sucient to lead to a growth-factor-independent phenotype and protection from apoptosis in the absence of growth factor but would not be able to provide signals sucient to protect cEpoR-transfected cells from etoposide and serum-deprivation-induced-apoptosis.
The precise mechanisms of growth factor independence induced by BCR ± ABL in hematopoietic cell lines are unknown. It is still unclear whether this eect has any relevance with regard to human CML, either at diagnosis or during disease progression. As a matter of fact there is no growth factor independence in primary clonogenic CML cells except for some subtle abnormalities such as Epoindependent behavior (Eaves and Eaves, 1987) or Steel factor-induced erythroid dierentiation (Issaad and Vainchenker, 1994) . How and if STAT activation has any relevance with regard to the antiapoptotic eect of BCR ± ABL remains to be determined and awaits experiments with either antisense STAT oligonucleotides or dominant-negative STAT molecules in BCR ± ABL expressing hematopoietic cells. Our results in Ba/F3 cell line indicate that growth factor independence and inhibition of apoptosis can be dierentially induced by two oncogenes (i.e., BCR ± ABL and cEpoR) and are accompanied by a dierential activation of STAT molecules in the same cellular context. They also suggest that STAT factor activation might be a major eect underlying the antiapoptotic potential of BCR ± ABL. There is recent experimental evidence linking inhibition of STAT factors to apoptosis (Bright et al., 1997; Naka et al., 1997) . Our results provide therefore a rationale for further study of the involvement of STAT factors in the antiapoptotic action of BCR ± ABL oncogenes.
Materials and methods
Cells
Ba/F3 cell line was generously provided by G Krystal (Terry Fox Laboratory) and maintained in RPMI containing 10% FCS and 10% WEHI-CM. For some experiments the recombinant mIL-3 was used at a concentration of 10 ng/ml.
Plasmids
Full-length cDNA for p210 BCR ± ABL was provided by Dr RK Humphries (Terry Fox Laboratory, Vancouver, Canada) . cDNA for p190 BCR ± ABL was obtained from E Canaani (Weizmann Institute of Science, Rehovot, Israel). The pXMcEpoR plasmid containing cEpo-R cDNA subcloned between KpnI and EcoRI sites was obtained from Dr Gregory Longmore (Washington University School of Medicine, St Louis, MO).
Construction of retroviral vectors
Murine stem cell vectors (MSCV) developed and generously provided by Dr RG Hawley (Toronto) were used in all gene transfer experiments. These vectors contain modi®cations of their 5' and 3' LTR's and allow high levels of heterologous gene expression in ES cells (Hawley et al., 1994) . MSCV-p210 vectors were constructed by subcloning the 6.5 kb EcoRI fragment from the pK562 plasmid into the EcoRI site of the MSCVNeo2.1 vector in the 5' ± 3' orientation. To construct MSCV p190, we have used the pSP65 ± p190 plasmid which contained the full length cDNA cloned between EcoRI and HindIII. The HindIII site was ®rst transformed into an EcoRI site using EcoRI linkers (New England Biolabs). The resulting plasmid was digested by EcoRI and the 6 kb fragment was subcloned in the 5' ± 3' orientation into the dephosphorylated MSCVNeo 2.1 construct. To construct MSCV-cEPOR, the KpnI site of pXMcEPOR was transformed into an EcoRI site using EcoRI linkers and the resulting 1.6 kb EcoRI-EcoRI fragment was subcloned into the EcoRI site of MSCV Neo 2.1. All plasmids were puri®ed using ultracentrifugation through CsC1 gradients.
Electroporation and cell cloning
Gene transfer into Ba/F3 cells was accomplished using a Cell-ject electroporator (Eurogentec, Brussels, Belgium) 20 ± 30 mg of puri®ed plasmid were electroporated into 5. 10 6 cells using the following protocol: Cells were fed the day prior to electroporation (250 V, 1500 microF). Following a medium change performed 24 h later, cells were expanded for another 24 h before being subjected to a G418 selection (1 mg/ml, Life Technologies, MD) in a semi-solid medium (Methylcellulose, Stem cell Technologies, Inc, Vancouver, Canada) at day 2, either in the presence of G418 (1 mg/ml) plus 10% WEHI-CM or in the absence of both. Cell concentrations ranging from 1000 ml up to 10 000 per ml were used to determine cloning and gene transfer eciencies. Colonies growing in the presence of G418 (1.0 mg/ml) and 10% WEHI-CM, were individually plucked and ampli®ed. A fraction of each clone was then frozen and cells were tested for growth-factorindependence.
Epo-binding assays
In order to determine if the transfected EpoR construct was eectively expressed at the cell surface of Ba/F3 cells, we have used a radioactive Epo binding assay. Parental Ba/ F3 cells, polyclonal cEpoR cells as well as four individual Ba/F3 clones which we rendered growth-factor-independent by transfection of the cEpoR, were incubated for 1 h at 378C with 2 nM iodinated Epo. Non-speci®c binding was determined by incubating the cells with 500 mM unlabeled Epo. After this period of incubation, cells were washed three times with ice cold phosphate buer saline and the radioactivity associated with cells was measured by gamma counting.
Cell proliferation assays
Cell proliferation assays were performed using standard thymidine incorporation technique in 96-well plates. 10 4 cells were cultured for 48 h with and without growth factors at 378C and then incubated with 3 H-TdR (Amersham) for 18 h at a concentration of 1 mCi per well. Thymidine incorporation was determined using a Betaplate counter (LKB Wallac; St Quentin-en-Yvelines, France).
Western blotting
0.4 ± 1 10 6 cells were lysed in Laemmli lysis buer, loaded on a 7.5% (BCR ± ABL) or 12.5% (Bc12/Bax) SDSpolyacrylamide gel, separated by electrophoresis, and electrotransferred onto nitrocellulose ®lters. Blots were incubated in 5% milk, 10 mM Tris, 137 mM NaCl, 0.1% Tween (blocking solution) for 2 h before adding the antibody (anti-abl, Ab-3, Oncogene Science; Polyclonal anti-bc12 and Polyclonal anti-Bax, Santa Cruz Inc Tebu, France) for 18 h at 48C. Immune complexes were detected by enhanced chemiluminescence detection system (ECL, Amersham Corp. Arlington Heights, IL) using horse radish peroxydase coupled antibodies (anti-mouse IgG1 and for BCR ± ABL an anti-rabbit-IgG for Bc12 and Bax) (Amersham).
Electrophoretic mobility shift assay (EMSA)
Permanently growing Ba/F3 cells expressing BCR ± ABL or cEpoR were washed in serum-free medium and nuclear extracts were prepared and incubated with 10 ± 15 fmol of a 32 P-labeled oligonucleotide as previously described . As a control, Ba/F3-NeoR cells were deprived of cytokine-containing medium for 18 h and incubated in the presence of recombinant IL-3 (10 ng/ml) or IFN-g (1000 U/ml) for 10 min. After washing, nuclear extracts were prepared from the control and transfectant clones. Each oligonucleotide probe (SIEm67, 5'-CAT TTCCCGTAAATC-3'; IRF1-GAS 5'-GATCCATTTC CCCGAAATGA-3'; b-Casein-GAS 5'-AGATTCTAG-GAATTCAAATC-3') was end-labeled using T4 polynucleotide kinase to a speci®c activity of 8000 c.p.m./fmol .
Induction of apoptosis
To induce apoptotic death in dierent cell lines, we have used stimuli including serum deprivation, growth factor deprivation (IL-3 for Ba/F3 and Epo for Ba/F3 transfected with the wild-type EpoR) or etoposide. To determine the optimal concentration of etoposide in parental Ba/F3 cell line, preliminary experiments were performed using etoposide doses ranging from 5 mg/ml to 30 mg/ml. The concentration of 20 mg/ml was found to induce apoptotic death in 495% of cells as determined by the quantitative FACS analysis. Therefore, this concentration was used in all experiments. To induce apoptosis by growth factor or serum deprivation, cells were washed twice in PBS and were grown in RPMI supplemented with Glutamax (Gibco BRL-Life Technologies, Paisley, Scotland) with or without addition of 10% WEHI-CM for 48 h and then tested for apoptosis. To determine if the apoptotic eect was not due to accumulation of free radicals in the RPMI medium rather than to the serum deprivation, each experiment was repeated in RPMI medium reconstituted prior to the experiment from powder according to the manufacturer's recommendatinos (Gibco BRL-Life Technologies, Paisley, Scotland).
Quantitative FACS-based assay for apoptosis
This assay was performed as described by Nicoletti et al., 1991. Brie¯y, 2.5. 10 6 Ba/F3 cells treated with either etoposide (20 microgrammes per ml) or grown in the absence of growth factors or serum, were centrifuged and washed once in PBS. They were suspended in a 1.5 ml solution containing Triton-X 100 0.1%, NaCitrate 0.1%, and propidium iodide 50 microgrammes/ml (Sigma) in polypropylene tubes at 48C overnight. The samples were analysed the following day using a FACScan¯ow cytometer (Becton and Dickinson, Mountain View, CA, USA). Apoptotic nuclei appeared to be easily distinguishable and quanti®able in this assay due to high low side scatter signal generated by the condensed nuclear chromatin.
